Skip to main content

Counts and Characteristics of Long-Acting Injectable Antipsychotic (LAIA) Users: A Descriptive Analysis

Basic Details
Date Posted
Status
Complete
Medical Product
long-acting injectable antipsychotics
Description

In this report we examined counts of individuals exposed to long-acting injectable antipsychotics (LAIA) in the Sentinel Distributed Database (SDD) and described demographic, health and treatment characteristics of these individuals.

The study period includes data from January 1, 2010 to December 31, 2021. We distributed this request to one Sentinel Data Partner on September 27, 2022. 

Deliverables (1)
Sentinel Modular Program Report: Counts and Characteristics of Long-Acting Injectable Antipsychotic (LAIA) Users: A Descriptive Analysis
Additional Details
FDA Center
CDER
Time Period
January 1, 2010 – December 31, 2021
Analysis Type
Descriptive
Population / Cohort
Individuals 18 years of age and older
Data Sources
Sentinel Distributed Database (SDD)
Related Links
Sentinel Drug Study: Long-Acting Injectable Antipsychotics & Mortality